Ayushman Hospital And Research Centre Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 19-12-2024
- Paid Up Capital ₹ 2.84 M
as on 19-12-2024
- Company Age 29 Year, 4 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.50 M
as on 19-12-2024
- Revenue -3.72%
(FY 2022)
- Profit 2.49%
(FY 2022)
- Ebitda -3.09%
(FY 2022)
- Net Worth 10.19%
(FY 2022)
- Total Assets 6.04%
(FY 2022)
About Ayushman Hospital And Research Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 2.84 M.
The company currently has active open charges totaling ₹7.50 M.
Rajnish Jaiswal, Rakesh Jain, and Saroj Gupta serve as directors at the Company.
- CIN/LLPIN
U85110MP1995PTC010289
- Company No.
010289
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Dec 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Satna, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ayushman Hospital And Research Centre?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajnish Jaiswal  | Managing Director | 25-Sep-2002 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rakesh Jain | Director | 21-Dec-1995 | Current |
| Saroj Gupta | Director | 21-Dec-1995 | Current |
Financial Performance of Ayushman Hospital And Research Centre.
Ayushman Hospital And Research Centre Pvt Ltd, for the financial year ended 2022, experienced Minor drop in revenue, with a 3.72% decrease. The company also saw a slight improvement in profitability, with a 2.49% increase in profit. The company's net worth Soared by an impressive increase of 10.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ayushman Hospital And Research Centre?
In 2020, Ayushman Hospital And Research Centre had a promoter holding of 89.61% and a public holding of 10.39%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Icici Home Finance Creation Date: 28 Feb 2003 | ₹3.50 M | Open |
Madhya Pradesh Financial Corporation Creation Date: 25 Apr 1997 | ₹4.00 M | Open |
How Many Employees Work at Ayushman Hospital And Research Centre?
Unlock and access historical data on people associated with Ayushman Hospital And Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ayushman Hospital And Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ayushman Hospital And Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
